1-3 of 3
Koichi Nagai
Close
Sort by
Journal Articles

Early Responses At 3 Months and 12 Months After Starting Imatinib As Predictive Factors For The Achievement Of Deep MR In Japanese CML Patients

Masayoshi Masuko, MD, PhD, Tatsuo Furukawa, MD, PhD, Tadashi Koike, MD, Kazue Takai, MD, Koichi Nagai, MD, Kenji Kishi, MD, PhD, Yoshinobu Seki, MD, Hoyu Takahashi, MD, PhD, Sadao Aoki, MD, PhD, Takashi Kozakai, MD, Yasuhiko Shibasaki, MD, Takashi Ushiki, MD, Ken Toba, MD, PhD, Miwako Narita, MD, PhD, Masuhiro Takahashi, MD, PhD, Hirohito Sone, MD, PhD, Akira Shibata, MD
Journal: Blood
Blood (2013) 122 (21): 2744.
https://doi.org/10.1182/blood.V122.21.2744.2744
Published: 2013
Journal Articles

Correlation Between Imatinib Trough Concentration and Long-Term Tolerability in CML Patients

Masayoshi Masuko, MD, PhD, Tatsuo Furukawa, MD, PhD, Toyoyuki Tanaka, MD, Syukuko Miyakoshi, MD, Takashi Kozakai, MD, Kyoko Fuse, MD, Yasuhiko Shibasaki, MD, Kazue Takai, MD, Yoshinobu Seki, MD, Masashi Kobayashi, MD, Koichi Nagai, MD, Hoyu Takahashi, MD, Kenji Kishi, MD, PhD, Miwako Narita, MD, PhD, Masuhiro Takahashi, Tadashi Koike, MD, Akira Shibata, MD
Journal: Blood
Blood (2012) 120 (21): 3751.
https://doi.org/10.1182/blood.V120.21.3751.3751
Published: 2012
Journal Articles

Fibrinogen Niigata With Impaired Fibrin Assembly: An Inherited Dysfibrinogen With a Bβ Asn-160 to Ser Substitution Associated With Extra Glycosylation at Bβ Asn-158

Teruko Sugo, Chizuko Nakamikawa, Hiroshi Takano, Jun Mimuro, Shu-ichi Yamaguchi, Michael W. Mosesson, David A. Meh, James P. DiOrio, Noriko Takahashi, Hoyu Takahashi, Koichi Nagai, Michio Matsuda
Journal: Blood
Blood (1999) 94 (11): 3806–3813.
https://doi.org/10.1182/blood.V94.11.3806
Published: 1999